Frank Kalkbrenner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Frank kalkbrenner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Frank Kalkbrenner Today - Breaking & Trending Today

AUROBAC THERAPEUTICS welcomes two new independent members to its Board: Manos Perros, as ...

Lyon - France, July 24, 2023 (GLOBE NEWSWIRE) AUROBAC THERAPEUTICS WELCOMES TWO NEW INDEPENDENT MEMBERS TO ITS BOARD: MANOS PERROS, AS CHAIRMAN, AND MARCO TAGLIETTI ....

Karl Penz , Antonio Felici , Frank Kalkbrenner , Marco Taglietti , Philippe Archinard , Scynexis Inc Nasdaq , Boehringer Ingelheim , Manos Perros , Independent Members , Thursday July , Independent Board , Chief Executive Officer , Entasis Therapeutics , Independent Member ,

Hong Kong Science and Technology Parks Corporation: HKSTP and Boehringer Ingelheim Venture Fund Launch Co-Incubation Programme to Fast-track R&D in Infectious Diseases and Immunology

Hong Kong Science and Technology Parks Corporation (HKSTP) is partnering global research-driven biopharmaceutical leader, Boehringer Ingelheim Venture Fund Limited (BIVF) in a strategic co-incubation ....

Yuen Long , Hong Kong General , Hong Kong , Karmen Cheung , Frank Kalkbrenner , Felix Gutsche , Tseung Kwan , Guangdong Hong Kong , Albert Wong , Bio Comms , Technology Parks Corporation , Venture Fund , Head Of Institute , Boehringer Ingelheim , Incu Bio Programme , Business Development Licensing , Boehringer Ingelheim Venture Fund , Research Beyond Borders , Institute For Translational Research , Boehringer Ingelheim Venture Fund Limited , Boehringer Ingelheim Venture Fund Gmb , Translational Research , Hong Kong Science , Grace Lau , Global Head , External Innovation Hub ,

Investegate |Destiny Pharma PLC Announcements | Destiny Pharma PLC: Conference Attendance for May 2021

A
Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
1. Obtains access to the information in a personal capacity;
2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so; ....

Brighton And Hove , United Kingdom , Bioequity Europe , Henry Skinner , Shaun Claydon , Steve Usdin , William Love , Frank Kalkbrenner , Neil Clark , John Rex , Strategic Communications , Action Fund , Cg Ltd , Growth Company , Virtual Forum , Boehringer Ingelheim Venture Fund , Destiny Pharma , Pharma Conference Attendance , Leading Growth Company , Equity Europe , Next Act , Senior Editor , Head Policy , Global Head , Chief Medical Officer , Chief Executive Officer ,

Investors Back Spinout's Therapy Developments for SNHL Labmate Online

May 01 2021 Read 4 Times
University of Sheffield spinout company, Rinri Therapeutics, has raised a total of £10 million from existing investors Boehringer Ingelheim Venture Fund (BIVF), UCB Ventures and BioCity alongside the UK Government Future Fund, to support the development of its novel stem cell therapy to treat sensorineural hearing loss (SNHL).
The company’s underlying technology is based on innovative research into auditory stem cells led by Professor Marcelo Rivolta at the University of Sheffield. It seeks to reverse SNHL through the repair of the damaged cytoarchitecture in the inner ear.
SNHL happens when there is damage to the hair cells in the cochlea and/or to the auditory nerve. There are currently no pharmacological treatments available for SNHL despite the increasing number of patients that suffer from this condition globally. ....

United Kingdom , Marcelo Rivolta , Simon Chandler , Frank Kalkbrenner , United Kingdom Government Future Fund , Boehringer Ingelheim Venture Fund , United Kingdom Future Fund , University Of Sheffield , Rinri Therapeutics , Professor Marcelo Rivolta , United Kingdom Future , Global Head , ஒன்றுபட்டது கிஂக்டம் , சிமோன் சாண்ட்லர் , ஒன்றுபட்டது கிஂக்டம் அரசு எதிர்கால நிதி , போஹெரிங்கர் இஂகல்‌ஹைம் துணிகர நிதி , ஒன்றுபட்டது கிஂக்டம் எதிர்கால நிதி , பல்கலைக்கழகம் ஆஃப் ஷெஃபீல்ட் , ஒன்றுபட்டது கிஂக்டம் எதிர்கால , உலகளாவிய தலை ,

Rinri Therapeutics Raises £10 million from Existing Investors and UK Future Fund to Advance its Novel Stem Cell Therapy to Restore Hearing Loss

Rinri Therapeutics Raises £10 million from Existing Investors and UK Future Fund to Advance its Novel Stem Cell Therapy to Restore Hearing Loss
News provided by
Share this article
Share this article
SHEFFIELD, England, April 20, 2021 /PRNewswire/ Rinri Therapeutics, a biotechnology company developing a novel stem cell therapy to restore hearing, today announces that it has raised a total of £10 million from existing investors Boehringer Ingelheim Venture Fund (BIVF), UCB Ventures and BioCity alongside the UK Government Future Fund. The proceeds will support the development of the Company s novel stem cell therapy to reverse sensorineural hearing loss (SNHL).
Rinri s underlying technology, based on innovative research into auditory stem cells led by Professor Marcelo Rivolta at the University of Sheffield from where the company was spun out, seeks to reverse SNHL through the repair of the damaged cytoarchitecture in the inner ear. SNHL happens when there is ....

United Kingdom , Frazer Hall , Marcelo Rivolta , Simon Chandler , Frank Kalkbrenner , Sylvie Berrebi , Citigate Dewe Rogerson , British Business Bank , United Kingdom Government Future Fund , Boehringer Ingelheim Venture Fund , United Kingdom Future Fund , University Of Sheffield , Rinri Therapeutics , United Kingdom Government Future , Professor Marcelo Rivolta , United Kingdom Future , Global Head , British Business , ஒன்றுபட்டது கிஂக்டம் , ஃப்ரேசர் மண்டபம் , சிமோன் சாண்ட்லர் , பிரிட்டிஷ் வணிக வங்கி , ஒன்றுபட்டது கிஂக்டம் அரசு எதிர்கால நிதி , போஹெரிங்கர் இஂகல்‌ஹைம் துணிகர நிதி , ஒன்றுபட்டது கிஂக்டம் எதிர்கால நிதி , பல்கலைக்கழகம் ஆஃப் ஷெஃபீல்ட் ,